72196

Magnetic resonance (eg, proton) imaging, pelvis; with contrast material(s)

Magnetic Resonance Imaging (MRI) of the pelvis with contrast material is an advanced, non-invasive diagnostic imaging procedure utilized to evaluate the soft tissues, organs, and vascular structures within the pelvic region. This specific CPT code, 72196, designates an MRI study where gadolinium-based intravenous contrast material is administered prior to or during the primary imaging sequences to enhance the visibility of tissues, particularly aiding in the differentiation of benign from malignant lesions, assessing the vascularity of masses, and identifying areas of active inflammation or infection. The pelvic region encompasses the urinary bladder, reproductive organs (such as the uterus, ovaries, and fallopian tubes in females; the prostate gland and seminal vesicles in males), the distal gastrointestinal tract (rectum and anus), pelvic lymph nodes, and the surrounding musculature and bony pelvis. The procedure involves the patient lying supine on a specialized table that slides into the cylindrical MRI scanner. A radiofrequency coil is typically placed over the patient's pelvis to optimize signal reception. High-frequency radio waves and a strong magnetic field are utilized to align hydrogen protons in the body, creating detailed cross-sectional images in multiple planes (axial, sagittal, and coronal). The addition of contrast material significantly improves the diagnostic yield when evaluating oncological conditions, such as staging prostate, cervical, endometrial, or rectal cancer, by highlighting areas of hypervascularity typical of neoplastic growth. It is also highly effective in delineating complex perianal fistulas, assessing severe pelvic inflammatory disease, and characterizing indeterminate adnexal masses. The radiologist reviews the contrast-enhanced sequences, often comparing them with specific fluid-sensitive or fat-suppressed sequences, to formulate a comprehensive interpretation. The use of this code specifically implies that the diagnostic sequences relied upon were obtained after the administration of the contrast agent, without a preceding full set of non-contrast diagnostic sequences (which would be coded as 72197). To ensure maximum patient safety, renal function is verified beforehand since gadolinium is cleared by the kidneys. Overall, CPT 72196 plays a vital role in modern diagnostic medicine, offering unparalleled soft-tissue contrast and functional tissue assessment within the anatomically complex pelvic cavity.

Clinical Indications

  • Staging and evaluation of primary pelvic malignancies including prostate, cervical, endometrial, ovarian, bladder, and rectal cancers.
  • Characterization of indeterminate pelvic masses, cysts, or lesions identified on prior imaging modalities like ultrasound or computed tomography.
  • Evaluation of complex perianal fistulas, perianal abscesses, or other manifestations of inflammatory bowel disease in the pelvic region.
  • Assessment of acute or chronic pelvic inflammatory disease and complex tubo-ovarian abscesses.
  • Identification and detailed mapping of deep infiltrating endometriosis.
  • Evaluation of vascular malformations or aneurysms within the pelvic vasculature.
  • Follow-up assessment of known pelvic tumors post-chemotherapy, post-radiation, or following surgical resection to differentiate residual or recurrent tumor from post-treatment fibrosis.

Procedure Steps

  1. Conduct a thorough safety screening to ensure the patient has no contraindicated implanted metallic or electronic devices and assess renal function prior to gadolinium administration.
  2. Establish intravenous access in the patient's arm or hand for the administration of the contrast material.
  3. Position the patient supine on the MRI table and place a specialized phased-array pelvic radiofrequency coil over the target anatomical area to maximize image quality.
  4. Administer the appropriate weight-based dose of gadolinium intravenous contrast material via the intravenous line, using either manual injection or a power injector.
  5. Acquire contrast-enhanced multi-planar imaging sequences using various pulse sequences to evaluate the enhancement patterns of pelvic structures and potential pathology.
  6. Remove the patient from the MRI scanner, discontinue the intravenous line, and ensure the patient is clinically stable before discharge.
  7. Process the acquired imaging data for the radiologist to review, evaluate anatomical integrity and pathological enhancement, and generate a formal diagnostic report.

Coding Guidelines

  • CPT code 72196 should be used exclusively when the MRI of the pelvis is performed with contrast material only, without a preceding non-contrast study.
  • Do not report 72196 in conjunction with 72195 (MRI pelvis without contrast) or 72197 (MRI pelvis without and with contrast) for the same patient, on the same anatomical site, during the same session.
  • The supply of the injectable gadolinium-based contrast material is not included in the procedure code and should be reported separately using the appropriate HCPCS Level II code.
  • If the procedure is performed in a hospital or facility setting, the physician interpreting the scan should append modifier 26 to indicate the professional component.
  • If the provider owns the equipment and performs the scan but does not provide the interpretation, append modifier TC to indicate the technical component.
  • Ensure the medical record explicitly documents the medical necessity for utilizing contrast material and lists the specific type and volume of contrast administered.

Associated ICD-10 Codes